DavidGMutchMD

PubMed

• 1 citations
  Gestational choriocarcinoma.
  Bogani, G., Ray-Coquard, I., Mutch, D., Vergote, I., Ramirez, P., Prat, J., Concin, N., Ngoi, N., Coleman, R., Enomoto, T., Takehara, K., Denys, H., Lorusso, D., Takan...> ;International Journal of Gynecological Cancer. 2023 Oct 2
• 4 citations
  Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival.
  Emilee N Kotnik, Mary M Mullen, Nicholas C Spies, Tiandao Li, Matthew Inkman, Jin Zhang, Fernanda Martins-Rodrigues, Ian S Hagemann, Carolyn K McCourt, Premal H Thaker...> ;Communications Biology. 2023 Jul 3
• Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery.
  Abigail S Zamorano, Angela L Mazul, Christine Marx, Mary M Mullen, Molly Greenwade, L Stewart Massad, Carolyn K McCourt, Andrea R Hagemann, Premal H Thaker, Katherine ...> ;Gynecologic Oncology Reports. 2022 Dec 1
• 1 citations
  Gynecologic oncology patient perspectives and knowledge on advance care planning: A quality improvement intervention.
  Sarah P Huepenbecker, Sophia Lewis, Mark C Valentine, Marguerite L Palisoul, Premal H Thaker, Andrea R Hagemann, Carolyn K McCourt, Katherine C Fuh, Matthew A Powell, ...> ;Gynecologic Oncology Reports. 2022 Oct 1
• 2 citations
  High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancer.
  Elizabeth Buckley, Mary M Mullen, Rehan A Nizamuddin, Jonathan H Stein, Lindsay M Kuroki, Katherine C Fuh, Andrea R Hagemann, Carolyn K McCourt, David Mutch, Dineo Kha...> ;Gynecologic Oncology. 2022 Dec 1
• 2 citations
  Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopy.
  Xiandong Leng, Sitai Kou, Yixiao Lin, Andrea R Hagemann, Ian S Hagemann, Premal H Thaker, Lindsay M Kuroki, Carolyn K McCourt, David G Mutch, Cary Siegel, Matthew A Po...> ;Scientific Reports. 2022 Sep 23
• 1 citations
  Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncolog...
  Yovanni Casablanca, Guisong Wang, Heather A Lankes, Chunqiao Tian, Nicholas W Bateman, Caela R Miller, Nicole P Chappell, Laura J Havrilesky, Amy Hooks Wallace, Nilsa ...> ;Cancers. 2022 Aug 23
• Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission to...
  Tyler R Mckinnish, Molly M Greenwade, Ivy Wilkinson-Ryan, Julie K Schwarz, Matthew A Powell, David G Mutch, L Stewart Massad, Perry W Grigsby, Barry A Siegel, Premal H...> ;Gynecologic Oncology. 2022 Jul 1
• 3 citations
  Overall survival in patients with FIGO stage IVA cervical cancer.
  Joshua P Schiff, Rachel Mintz, Alexander C Cohen, Yi Huang, Premal Thaker, Leslie S Massad, Matthew Powell, David Mutch, Julie K Schwarz, Stephanie T Markovina, Perry ...> ;Gynecologic Oncology. 2022 Aug 1
• The impact of tumor size and histology on local control when utilizing high-dose-rate interstitial brachytherapy for gynecologic malignancies.
  Joshua P Schiff, Mustafaa Mahmood, Yi Huang, Matthew A Powell, David Mutch, Pawel T Dyk, Alexander J Lin, Julie K Schwarz, Stephanie T Markovina, Perry W Grigsby> ;Gynecologic Oncology. 2022 Jun 1
• 4 citations
  GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis.
  Shaina F Bruce, Kevin Cho, Hollie Noia, Elena Lomonosova, Elizabeth C Stock, Alyssa Oplt, Barbara Blachut, Mary M Mullen, Lindsay M Kuroki, Andrea R Hagemann, Carolyn ...> ;Molecular Cancer Therapeutics. 2022 Aug 2
• 8 citations
  Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259).
  Heidi S Donovan, Susan M Sereika, Lari B Wenzel, Robert P Edwards, Judith E Knapp, Susan H Hughes, Mary C Roberge, Teresa H Thomas, Sara Jo Klein, Michael B Spring, Su...> ;Journal of Clinical Oncology. 2022 May 1
• 27 citations
  Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial.
  Matthew A Powell, Virginia L Filiaci, Martee L Hensley, Helen Q Huang, Kathleen N Moore, Krishnansu S Tewari, Larry J Copeland, Angeles A Secord, David G Mutch, Alessa...> ;Journal of Clinical Oncology. 2022 Mar 20
• 2 citations
  The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer.
  Pratibha S Binder, Yassar M Hashim, James Cripe, Tommy Buchanan, Abigail Zamorano, Suwanna Vangveravong, David G Mutch, William G Hawkins, Matthew A Powell, Dirk Spitzer> ;BMC Cancer. 2022 Mar 12
• 7 citations
  Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care.
  Shaina F Bruce, Bridget Huysman, Jinai Bharucha, L Stewart Massad, Mary M Mullen, Andrea R Hagemann, Katherine C Fuh, Carolyn K McCourt, Premal H Thaker, Dineo Khabele...> ;Gynecologic Oncology Reports. 2022 Feb 1
• 4 citations
  Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An N...
  Ursula A Matulonis, Helen Q Huang, Virginia L Filiaci, Marcus Randall, Paul A DiSilvestro, Katherine M Moxley, Jeffrey M Fowler, Matthew A Powell, Nick M Spirtos, Kris...> ;Gynecologic Oncology. 2022 Feb 1
• 5 citations
  Tumor Lysis Syndrome in a Patient With Metastatic Endometrial Cancer Treated With Lattice Stereotactic Body Radiation Therapy.
  Joshua Schiff, Matthew B. Spraker, Sai Duriseti, Sana Shaikh, Haris F. Murad, David G. Mutch, Clifford G. Robinson, J. Kavanaugh, Alexander J. Lin> ;Advances in Radiation Oncology. 2022 Jan 1
• 3 citations
  Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer
  Michael D. Toboni, Elena Lomonosova, Shaina Bruce, Joan Tankou, Mary M. Mullen, Angela Schab, Alyssa Oplt, Hollie Noia, Danny Wilke, Lindsay M. Kuroki, Andrea R. Hagem...> ;Cancers. 2021 Nov 23
• 12 citations
  GAS6/AXL inhibition enhances ovarian cancer sensitivity to chemotherapy and PARP inhibition through increased DNA damage and enhanced replication stress
  Mary M. Mullen, Elena Lomonosova, Michael D. Toboni, Alyssa Oplt, Emily Cybulla, Barbara Blachut, Peinan Zhao, Hollie Noia, Daniel Wilke, Erinn B. Rankin, Lindsay M. K...> ;Molecular Cancer Research. 2021 Oct 20
• 17 citations
  Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer.
  Lauren E. Henke, Jennifer A. Stanley, Clifford G. Robinson, A. Srivastava, Jessika Contreras, A. Curcuru, Olga Green, L. Stewart Massad, Lindsay M. Kuroki, Katherine F...> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Aug 30
• 90 citations
  Uterine neoplasms, version 3.2021 featured updates to the NCCN guidelines
  Nadeem R. Abu-Rustum, Catheryn M. Yashar, Kristin A. Bradley, Susana M. Campos, Junzo Chino, Hye Sook Chon, Christina Chu, David E. Cohn, Marta A. Crispens, Shari Dama...> ;Journal of the National Comprehensive Cancer Network. 2021 Aug 1
• 8 citations
  Text-message-based behavioral weight loss for endometrial cancer survivors with obesity: A randomized controlled trial.
  Abigail S. Zamorano, Elise Wilson, Jingxia Liu, A. Leon, Lindsay M. Kuroki, Premal H. Thaker, Carolyn K. McCourt, Katherine Fuh, Matthew A. Powell, David G. Mutch, Bra...> ;Gynecologic Oncology. 2021 Sep 1
• 1 citations
  Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer.
  E.A. Johns, Jennifer A. Stanley, Michael D. Toboni, Julie K. Schwarz, F. Zhang, Andrea R. Hagemann, Katherine Fuh, Premal H. Thaker, Carolyn K. McCourt, David G. Mutch...> ;Gynecologic Oncology Reports. 2021 Jun 9
• 4 citations
  A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy.
  Mary M. Mullen, Tyler McKinnish, Mark A. Fiala, Abigail S. Zamorano, Lindsay M. Kuroki, Katherine Fuh, Andrea R. Hagemann, Carolyn K. McCourt, David G. Mutch, Matthew ...> ;Gynecologic Oncology. 2021 Jun 1
• 6 citations
  Impact of employment and insurance status on distress in gynecologic oncology patients.
  Lindsay M. Kuroki, David H. Morris, M. Greenwade, Megan Landon, Andrea R. Hagemann, Premal H. Thaker, L. Stewart Massad, Carolyn K. McCourt, Katherine Fuh, Matthew A. ...> ;Gynecologic Oncology. 2021 May 1
• Join now to see all

Journal Articles

• Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer  
  Ian S Hagemann, Premal H Thaker, Carolyn K McCourt, Katherine C Fuh, David G Mutch, Andrea R Hagemann, Matthew A Powell, Clinical Cancer Research
• Endometrial Carcinoma Recurrence According to Race and Ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study  
  M L Pearl, D S Miller, W T Creasman, P H Thaker, J F Boggess, S R Guntupalli, D G Mutch, J L Walker, O B Ioffe, D E Cohn, L S Downs, International Journal of Cancer
• Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer  
  Ian S Hagemann, Carolyn K McCourt, Matthew A Powell, Premal H Thaker, David G Mutch, Katherine C Fuh, Andrea R Hagemann, Clinical Cancer Research
• Bevacizumab-combination therapy in relapsed, platinum-refractory, epithelial ovarian carcinoma.  
  Wright JD, Hagemann A, Rader JS, Viviano D, Gibb RK, Norris L, Mutch DG, Powell MA, Cancer;107(1):83-9
• Gene therapy in gynecological cancer.  
  Brooks RA, Mutch DG, Expert Rev Anticancer Ther;6(7):1013-32
• Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy.  
  Zighelboim I, Taylor NP, Powell MA, Gibb RK, Rader JS, Mutch DG, Grigsby PW, Radiat Med 24:625-630
• A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer.  
  Wright JD, Secord AA, Numnum TM, Rocconi RP, Powell MA, Berchuck A, Alvarez RD, Gibb RK, Trinkaus K, Rader JS, Mutch DG, Int J Gynecol Cancer
• Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multi-institutional experience.  
  Huh WK, Straughn JM Jr, Mariani A, Podratz KC, Havrilesky LJ, Alvarez-Secord A, Gold MA, McMeekin DS, Modesitt S, Cooper AL, Powell MA, Mutch DG, Nag S, Alvarez RD, Co..., Int J Gynecol Cancer;17(4):886-9
• Effect of T0 radical hysterectomy specimen on survival for early stage cervical cancer.  
  Wright JD, Grigsby PW, Rader JS, Mutch DG, Powell MA, Gao F, Gibb RK, Gynecol Oncol
• The role of genetic testing for cancer susceptibility in gynecologic practice.  
  Karlan BY, Berchuck A, Mutch D, Obstet Gynecol;110(1):155-67
• Acute toxicity in postoperative IMRT and chemotherapy for endometrial cancer.  
  Tierney RM, Powell MA, Mith DG, Gibb RK, Rader JS, and Grigsby PW, Radiat Med. 25:439-445
• Society of Gynecologic Oncologists Education Committee. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic c...  
  Lancaster JM, Bethan Powell C, Kauff ND, Cass I, Chen LM, Lu KH, Mutch DG, Berchuck A, Karlan BY, Herzog TJ, Gynecol Oncol;107(2):159-62
• How to manage an adnexal mass.  
  Mutch DG, Bleckman CR, OBG Management. 19(12):50-58
• Bevacizumab therapy in patients with recurrent uterine neoplasms.  
  Wright JD, Powell MA, Rader JS, Mutch DG, Gibb RK, Anticancer Res; 27(5B):3525-8
• Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian cancer.  
  Nguyen TT, Wright JD, Powell MA, Gibb RK, Rader JS, Allsworth JE, Mutch DG, Int J Gynecol Cancer
• Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review.  
  Thomas M, Mariani A, Wright JD, Madarek EO, Powell MA, Mutch DG, Podratz KC, Dowdy SC, Gynecol Oncol;108(2):293-7
• Update on endometrial cancer.  
  Mutch DG, Rimel BJ, OBG Management Vol 20(7):35-42
• Effects of cancer treatment on ovarian function.  
  Stroud JS, Mutch DG, Rader JS, Powell MA, Thaker PH, Grigsby PW, Fertil & Steril
• Management of endometrial cancer.  
  Fowler W, Mutch DG, Women’s Health. Vol 4(5)
• A case report demonstrating unambiguous clinical utility of PET/CT scanning in recurrent ovarian cancer.  
  Mutch D, Markman M, Case Rep in Oncol: 2:121-124
• Meeting Report: The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas.  
  Mutch DG, Gyn Oncology:115:325-328
• Clinical outcomes of definitive IMRT with FDG-PET simulation in patients with locally advanced cervical cancer.  
  Grigsby PW, Dehdashti F, Rader JS, Mutic S, Mutch DG, Powell MA, Siegel BA, Int J Rad Oncol, Biology, Physics
• ASTEC lymphadenectomy and radiation studies: Are conclusions valid?  
  Creasman, WT, Mutch DG, Herzog TJ, Gynecologic Oncology116 293-294
• Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic disease.  
  Mutch, D.G., Soper, J.T., Baker, M.E., Bandy, L.C., Cox, E.B., Clarke-Pearson, D.L., and Hammond, and C.B, Obstet. Gynecol; 68:348-352
• Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal anti¬body.  
  Budwit, D.A., Cox, E.B., Soper, J.T., Mutch, D.G., McCarty, K.S., Sr., Creasman, W.T., and McCarty, K.S., and Jr, Cancer Res; 46:5419-5425
• Join now to see all

Books/Book Chapters

• Gynecology and Obstetrics. 
  Chapter: Gestational trophoblastic neoplasms 
  Hammond, C.B., Lewis, J.L., and Mutch, D.GEditors: Sciarra.Harper and Row, Publishers, Inc
• Malignant Trophoblastic Disease. 
  Chapter: The role of surgery in gesta¬tional trophoblastic disease 
  Soper, J.T., Mutch, D.G., and Hammond, C.BEditors: Buchsbaum, H. and Szulman, R.Springer-Verlag
• Manual of Emergency and Outpa¬tient Techniques. 
  Chapter: Obstetrics and Gynecology 
  Mutch, D.GEditors: Sicard, G. and Klippel, A.Little, Brown and Co
• Ovarian Cancer 2. 
  Chapter: TNF_ Mediated Lysis in Gynaecological Malig¬nancies 
  Mutch, D.G. and Collins, J.LEditors: Sharp, F., Mason, W.P, and Creasman, W.Chapman and Hall Medical
• Practical Gynecology: a Lange Clinical Manual. 
  Chapter: Benign diseases of the vulva 
  Massad, L.S. and Mutch, D.GEditors: Gast, M.J. and Jacobs, A.J.
• Gynecology and Obstetrics: An Integrated Approach. 
  Chapter: Gestational trophoblastic disease 
  Massad, L.S., Mutch, D.GEditors: Moore, T., Reiter, C, Rebar, R.W., Baker V.V.Churchill Livingstone, New York
• Textbook of Gynecology. 
  Chapter: Fallopian tube neoplasms 
  Mutch, D.G. and Massad, L.SEditors: Copeland, L.W.B Saunders Co
• Clinical Obstetrics and Gynecology. 
  Chapter: Biology of epithelial ovarian cancer 
  Mutch, D.G. and Williams, SEditors: Soper, J. T., and Varner, M. W.. B. Lippincott Co
• Handbook of Obstetrics and Gynecology. 
  Chapter: Complications of gynecologic surgery 
  Mutch, D.G. and Herzog, TEditors: Gast, M.J. and Jacobs, A.J.
• Conn's Current Therapy. 
  Chapter: Carcinoma of the uterine cervix 
  Mutch, D.GEditors: Rakel, R.W.B. Saunders Company
• Conn's Current Therapy. 
  Chapter: Neoplasms of the vulva 
  Easley, K.O. and Mutch, D.GEditors: Rakel, R.W.B. Saunders Company
• Clinical Obstetrics and Gynecology. 
  Chapter: Gynecologic surgery and oncology updates 
  Mutch, D.GEditors: Mutch D.G.Lippincott, Wiliams and Wilkins
• Glass’ Office Gynecology. 
  Chapter: Abnormal cytology and Human Papillomavirus 
  Buttin, B.M., Herzog, T.J., Mutch, D.GEditors: Curtis, M., Clarke-Pearson, D., Hopkins M.Lippincott, Williams and WilkinsEdition Sixt,
• Danforth’s Obstetrics and Gynecology. 
  Chapter: Uterine cancer 
  Mutch, D.GLippincott, Williams and Wilkins
• Principles and Practice of Gynecologic Oncology. 
  Chapter: Management of Late Effects of Treatment 
  Mutch D.GEditors: Hoskins W.J., Perez, C.A., Young R.C., Barakat R., Markman M., Randall M.E.Lippincott Williams and WilkinsEdition 4th,
• Gynecologic Cancer: Controversies in Management. 
  Chapter: Molecular Genetics of Endometrial Cancers 
  Mutch D.GEditors: Gershenson, D.M., McGuire, W.P., Gore, M., Quinn, M.A., Thomas, G.Elsevier
• Principles and Practice of Gynecologic Oncology. 
  Chapter: Management of Late Effects of Treatment 
  Mutch DGEditors: Hoskins WJ, Perez, CA, Young RC, Barakat R, Markman M., Randall M.E.Lippincott Williams and WilkinsEdition 4th,
• Clinical Gynecologic Oncology. 
  Chapter: Molecular and Clinical Genetics of Gynecologic cancers 
  Mutch DGEditors: Mutch DG, Mannel R, McMeekin S.ElsevierEdition 8th,
• Clinical Gynecologic Oncology. 
  DiSaia PJ, Creasman WT, Mannel RS, McMeekin DS, Mutch DGEditors: DiSaia PJ, Creasman WT, Mannel RS, McMeekin DS, Mutch DG (eds).ElsevierEdition 8th,
• Join now to see all

Abstracts/Posters

• Patterns of TP53 and KRAS 2 mutations in a large series of endometrial cancer characterized for DNA mismatch repair.
  Swisher EM, Pfeiffer-Schneider S, Mutch DG, Herzog TJ, Rader JS, Elbendary A, Goodfellow PJ, Society of Gynecologic Oncologists, Orlando, FL
• Comparison of a critical region of loss on chromosome 1p; ovarian papillary serous carcinoma is genetically distinct from uterine papillary serous carcinoma.
  Herzog TJ, Kowalski LD, Liu H, Elbendary A, Rader JS, Swisher EM, Mutch DG, Goodfellow PJ, Society of Gynecologic Oncologists, Orlando, FL
• Cancer among first-degree relatives of probands with invasive versus borderline ovarian cancer.
  Rader JS, Brady J, Babb S, Temple S, Herzog TJ, Azu J, Kost E, Mutch DG, Canel HM, Galakatos AE, Xian H, Neuman RJ, Society of Gynecologic Oncologists, Orlando, FL
• Liposomal doxorubicin in advanced relapsed gynecologic malignancies.
  Herzog TJ, Gandhi S, Swisher EM, Rader JS, Mutch DG, Elbendary AE, Society of Gynecologic Oncologists, San Francisco, CA
• The cost effiacy of carboplatin/taxol (3 hr infusion) vs cisplatin/taxol (24 hour infusion) in ovarian cancer.
  Elbendary AE, Younis H, Mutch DG, Herzog TJ, Society of Gynecologic Oncologists, San Francisco, CA
• Clinical characteristics and prognosis of endometrial cancers with and without microsatellite instability.
  Basil JB, Mutch DG, Goodfellow PJ, Rader JS, Elbendary AE, Herzog TJ, Society of Gynecologic Oncologists, San Francisco, CA
• Atypical clustering of gynecologic cancers: A family study including molecular analysis of tumors and search for mutations in candidate genes.
  Cohn DE, Mutch DG, Whelan AJ, Herzog TJ, Elbendary AE, Rader JS, Babb S, Goodfellow PJ, Society of Gynecologic Oncologists, San Francisco, CA
• Radical hysterectomy for Stage I cervical cancer in very obese women: Efficacy and patient selection.
  Swisher EM, Cohn DE, Elbendary AE, Herzog TJ, Rader JS, Mutch DG, Society of Gynecologic Oncologists, San Francisco, CA
• PSC 833 decreases Taxol resistance in ovarian cancer cells by decreasing the mutation rate.
  Herzog TH, Liu H, Mutch DG, Society of Gynecologic Oncologists, San Francisco, CA
• Transvaginal fine needle aspiration biopsy: A tool for evaluating palpable pelvic masses.
  Ylagan L, Mutch D, Davila RM, United States and Canadian Academy of Pathology Annual Meeting, New Orleans, LA
• Interim analysis of a Phase III randomized trial of DOXIL?/CAELYX? (D) versus Topotecan (T) in the treatment of patients with relapsed ovarian cancer.
  Gordon AN, Fleagle JT, Guthrie D, Parkins DE, Gore M, Lacave AJ, Mutch D, American Society of Clinical Oncologists
• Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port malfunction.
  Cohn DE, Basil JB, Mutch DG, Awantang R, Ferrell M, Herzog TJ, Society of Gynecologic Oncologists, San Diego, CA
• Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability.
  Cohn DE, Basil JB, Mutch DG, Herzog TJ, Rader JS, Venegoni AR, Gersell DJ, Goodfellow PJ, Thirty-First Annual Meeting of the Society of Gynecologic Oncologists, San Diego, California
• Genotypic and phenotypic progression in endometrial tumorigenesis: Determining when defects in DNA mismatch repair and KRAS2 occur.
  Cohn DE, Basil JB, Venegoni AR, Dintzis SM, Mutch DG, Elbendary A, Rader JS, Herzog TJ, Gersell DJ, Goodfellow PJ, SmithKline Beecham National Gynecologic Oncology Fellows’ Forum, San Diego, California
• Genotypic and phenotypic progression in endometrial tumorigenesis: Determining when defects in DNA mismatch repair and KRAS2 occur.
  Cohn DE, Basil JB, Venegoni AR, Dintzis SM, Mutch DG, Elbendary A, Rader JS, Herzog TJ, Gersell DJ, Goodfellow PJ, Annual Scientific Meeting of the St. Louis Gynecological Society, St. Louis, Missouri
• The significance of pneumatosis intestinalis or bowel perforation in patients with gynecologic malignancies.
  Cohn DE, Horowitz NS, Herzog TJ, Mutch DG, Rader JS, Bhalla S, Gibb RK, Thirty-Second Annual Meeting of the Society of Gynecologic Oncologists, Nashville, Tennessee
• Prospective evaluation of FDG-PET imaging in predicting groin lymph node metastasis from squamous cell cancer of the vulva.
  Cohn DE, Mutch DG, Rader JS, Dehdashti F, Siegel BA, Gordon SH, Herzog TJ, Thirty-Second Annual Meeting of the Society of Gynecologic Oncologists, Nashville, Tennessee
• Prospective evaluation of FDG-PET imaging in predicting groin lymph node metastasis from squamous cell cancer of the vulva.
  Cohn DE, Mutch DG, Rader JS, Dehdashti F, Siegel BA, Gordon SH, Herzog TJ, SmithKline Beecham National Gynecologic Oncology Fellows’ Forum, Tucson, Arizona
• Aberrant DNA methylation in endometrial cancer: A poor prognostic marker.
  Powell MA,Mutch DG, Herzog TJ, Rader JS, Basil J, Goodfellow PJ, Society of Gynecologic Oncologists
• Low level ribosomal DNA methylation in endometrial cancer is an independent marker of poor prognosis and is associated with African-American race.
  Powell MA, Mutch DG, Rader JS, Herzog TJ, Huang TH-M, Goodfellow PJ, St. Louis Gynecologic Society Annual Scientific Meeting
• Stage IC Adenocarcinoma of the Endometrium: Survival Comparisons of Surgically Staged Patients With and Without Adjuvant Radiation Therapy.
  Straughn JM, Huh WK., Orr JW, Kelly FJ, Roland PJ, Gold MA, Powell MA, Mutch DG, Howard R, Zhang Y, Partridge EE, Kilgore L, Austin JM, and Alvarez RD, Oral presentation 2002 SGO
• The role of Topotecan for extending the platinum-free interval in recurrent ovarian cancer: An in vitro study.
  Herzog TJ, Hua Jun, Horowitz NS, Gibb RK, Mutch DG, Society of Gynecologic Oncologist 33rd Annual Meeting, Miami, Florida
• MSI, hMLH1 methylation, and loss of mismatch repair analysis in endometrial carcinoma and atypical hyperplasia.
  Horowitz NS, Pinto K, Mutch DG, Herzog TJ, Rader JS, Gibb RK, Bocker-Edmonston T, and Goodfellow PJ, Society of Gynecologic Oncologist 33rd Annual Meeting, Miami, Florida
• Lymphvascular space invasion can be used to assign patients to radiation or lymphadenectomy as adjuvant therapy for unstaged endometrial cancer.
  Horowitz NS, Mutch DG, Gibb RK, Herzog TJ, Rader JS, Kim SM, Manolitsas TP, Fowler JM, and Cohn DE, Society of Gynecologic Oncologist 33rd Annual Meeting, Miami, Florida
• Clinical and Pathologic Analysis of Uterine Papillary Serous Carcinoma (UPSC) and the Importance of Lymphvascular Space Invasion.
  Powell MA, Horowitz NS, Mutch DG, Rader JS, Gibb RK, Herzog TJ, 2002 SKB Fellow’s Forum
• Join now to see all

Lectures

• Effects of Growth Factors, Cytokines and Immunoproteins. 
  Third Biennial International Forum on Ovarian Cancer, Charleston, South Carolina
• Current Issues and Controversies in Obstetrics and Gynecology. 
  Sloane Symposium Lecture, Columbia University
• Obligation of commitment to lifelong learning. 
  Sanford School of Medicine – University of South Dakota, Sioux Falls, South Dakota
• The importance of the tripartite mission for all: Patient care, research and teaching. 
  Sanford School of Medicine – University of South Dakota, Sioux Falls, South Dakota
• Join now to see all

Other

• Treatment Strategies and Prognosis of Endometrial Cancer, Cancer of the Uterine Endometrium - Advances and Controversies. 
  Garg, G. and Mutch. DG, J. Salvador Saldivar (Ed.), ISBN: 978-953-51-0142-0, InTech
  http://www.intechopen.com/articles/show/title/treatment-strategies-and-prognosis-in-endometrial-canc